WANBURY
Back to Balance Sheet
|
WANBURY Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹65 Cr | ₹60 Cr | ₹1,072 Cr | ₹934 Cr | ₹889 Cr |
What is the latest Contingent Liabilities ratio of WANBURY ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹65 Cr |
| Mar2024 | ₹60 Cr |
| Mar2023 | ₹1,072 Cr |
| Mar2022 | ₹934 Cr |
| Mar2021 | ₹889 Cr |
How is Contingent Liabilities of WANBURY Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹65 Cr | 9.00 | |
| Mar2024 | ₹60 Cr | -94.43 | |
| Mar2023 | ₹1,072 Cr | 14.78 | |
| Mar2022 | ₹934 Cr | 5.01 | |
| Mar2021 | ₹889 Cr | - | |
Compare Contingent Liabilities of peers of WANBURY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WANBURY | ₹856.3 Cr | -1.8% | -4.6% | 29% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,855.0 Cr | 2.4% | 7.1% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,550.0 Cr | -0.2% | 3.8% | 15.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,906.0 Cr | 1.8% | 10.9% | 48.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,632.0 Cr | 1% | 4% | 16.6% | Stock Analytics | |
| CIPLA | ₹107,427.0 Cr | 0.3% | -0.9% | -6% | Stock Analytics | |
WANBURY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WANBURY | -1.8% |
-4.6% |
29% |
| SENSEX | -2.9% |
-8% |
5.3% |
You may also like the below Video Courses